$MRNA · Schwab Network · 2026-11-05
说话者看好MRNA，理由是III期数据显示一款与Keytruda合作的药物使皮肤癌相关死亡减少约42%，且自今年年初以来呈上升趋势，但并非长期上升趋势。不过该股在255附近旧高点受阻，RSI在上升与下降趋势线之间方向未明；需突破任一侧才能明确看涨或看跌方向，若跌破238.25的5日EMA可能打开219。
逐段跳播
你这里的下一个名字也属于医疗保健板块，但它是一家制药公司，跌幅比一些其他公司稍大，Moderna下跌了4.3%，今年迄今为止它经常登上头条。
Your last name here is also in the healthcare sector, but it's a pharmaceutical company that has fallen a little more than some of the others, down 4.3% for Moderna, which has been making headlines a lot so far this year.
Moderna的大局：大家都通过其新冠疫苗认识他们，但他们也在做一些很酷的事情，比如与Keytruda的合作，以及他们提供的一种已进入第三阶段的药物，目前显示它可以将皮肤癌相关死亡减少约42%。
所以，这是好消息。因此，我在长期趋势中看好Moderna，我不该说长期上升趋势。自今年年初以来，它一直处于上升趋势。
Well, the big picture for Moderna: everyone knows them from their COVID vaccine, but they also have some cool things they're working on, like the partnership with Keytruda and the drug they've provided that's reached Phase 3, which currently shows it can reduce skin cancer-related deaths by about 42%.
So, this is good news. So, I like Moderna in a long-term trend, I shouldn't say a long-term upward trend. It has been on an upward trend since the beginning of this year.
我在这笔交易中的操作是“看跌价差”，2027年1月15日。你想买入行权价为200的看跌期权，并卖出行权价为210的看跌期权给别人。同样，我们在这里看到约4美元的价格差。你大约有71天。
同样，股票可以上涨、横盘或下跌，你仍然会是赢家。
My trade in this, "Pulse Put Spread", January 15, 2027. You want to own the put option at 200, and you want to sell the put option at 210 to someone else. Again, we are looking at a price difference of about $4 there.
You have about 71 days. Again, the stock can go up, move sideways, or go down, and you will still be a winner.
没错，我们在这里达到了最高水平，接近255的旧高点。我们未能维持在该水平之上。我们仍然有一条白色的陡峭上升趋势线，但我们现在发现自己再次处于原始上升通道形态的边界内。我们这里的低点，即红色蜡烛的底部接近217，如果我们继续走弱，它作为潜在支撑区域脱颖而出。
我们深蓝色的5日指数移动平均线238.25也与这条趋势线非常紧密地对齐。所以，如果我们跌破该水平，可能会为接近219的21日月度指数移动平均线打开大门。
That's right, we reached our highest levels here, our old highs near 255. We were unable to maintain our level above that level here. We still have a sharp upward trend line in white, but we now find ourselves once again within the boundaries of the original upward channel shape here.
Our low point here, the bottom of our red candle near 217, stands out as a potential support area if we continue to falter . Our 5-day exponential moving average in dark blue, 238.25, is also very closely aligned with this trend line.
So, if we break below that, it could open the door for our 21-day monthly exponential moving average near 219.
相对强弱指数（RSI）目前有点令人困惑。我们仍处于绿色的短期上升趋势线之上，但同时也有一条红色的较长期下降趋势线，我们一直未能突破。看起来似乎要突破了，但现在我们又回到了那条线下方。
因此，要寻找突破这两条线中任意一条的更强趋势，以获得更多关于最终看涨或看跌方向的指示。
The Relative Strength Index (RSI) is a bit confused at the moment. We still have our short upward trend line in green in play, but we also have a longer downward trend line in red here which we have failed to break through.
It seemed like it would happen, but now we're back to below that level as well. Therefore, look for a stronger trend breakout beyond either of them to get more indications of our ultimate bullish or bearish direction here.
所以，我们的成交量分布显示这里和这里各有一个节点。因此，根据我们对这里密集交易活动的分析，220和200这两个水平大约就是关注点。
So, our trading volume profile shows a node here and here. Therefore, the 220 and 200 levels are approximately points of interest in relation to our analysis of the intense trading activity here.
Moderna目前下跌4.5%，报246.38，但跌幅肯定没有我们今天在这轮抛售中关注的其他一些股票那么大。
Well, Moderna is down 4.5% at 246.38 at the moment, but certainly not as much as we've seen in some of the other stocks we're watching today in this sell-off.
这个频道对 $MRNA 的历次判断
Schwab Network 在这只股票上共 4 条判断，这里只列相邻的几条。